Estrogen receptor modulators, genistein and daidzein, inhibit cell migration, invasion, proliferation, and sphere formation in ovarian cancer via modulation of FAK and PI3K/AKT signaling (Chan et al. 2018). The gene discussed is PTK2; the disease is ovarian carcinoma.